Gordian Capital (Singapore)’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12K Hold
10
0.02% 75
2026
Q1
$9.2K Sell
10
-20
-67% -$20.3K 0.02% 89
2025
Q4
$32.2K Sell
30
-30
-50% -$28.7K 0.04% 89
2025
Q3
$45.8K Buy
60
+50
+500% +$37.2K 0.06% 104
2025
Q2
$7.79K Sell
10
-305
-97% -$237K 0.01% 102
2025
Q1
$260K Sell
315
-975
-76% -$811K 0.16% 75
2024
Q4
$997K Buy
1,290
+475
+58% +$393K 0.52% 47
2024
Q3
$722K Buy
815
+406
+99% +$365K 0.27% 46
2024
Q2
$370K Sell
409
-541
-57% -$433K 0.21% 52
2024
Q1
$739K Buy
+950
New +$676K 0.55% 28

Other funds holding LLY

Gordian Capital (Singapore)'s LLY Position: Q2 2026 in Review

Gordian Capital (Singapore) held its Eli Lilly (LLY) position steady in Q2 2026 at 10 shares worth $12K. The position accounts for 0.02% of the portfolio, ranked #75.

Gordian Capital (Singapore) first reported a position in LLY in Q1 2024 and has held it in 10 quarters since. The position peaked at $997K in Q4 2024. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Gordian Capital (Singapore) held 10 shares of Eli Lilly worth $12K as of Q2 2026.
  • Gordian Capital (Singapore) left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.02% of Gordian Capital (Singapore)'s portfolio in Q2 2026, its #75 holding.
  • Gordian Capital (Singapore) first reported a position in Eli Lilly in Q1 2024 and has held it in 10 quarters since.
  • Gordian Capital (Singapore)'s Eli Lilly position peaked at $997K in Q4 2024.
  • 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Gordian Capital (Singapore)'s 13F filing for Q2 2026, filed 13 Aug 2026.